Vise Technologies’s Twist Bioscience TWST Stock Holding History

Vise Technologies’s Portfolio TWST Stock Details TWST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$372K	Buy	+1,924	New	+$238K	﹤0.01%	1557

Other funds holding TWST

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return

Parnassus Investments San Francisco, California $33.8B AUM 31.08% 1-Year Est. Return

State of Michigan Retirement System Lansing, Michigan $22.6B AUM 32.98% 1-Year Est. Return

BI Asset Management Fondsmaeglerselskab Kobenhavn, Denmark $13.1B AUM 35.37% 1-Year Est. Return

Harbor Capital Advisors Chicago, Illinois $1.48B AUM 30.88% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $57B AUM 43.56% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return

D.A. Davidson & Co Great Falls, Montana $18.6B AUM 17.65% 1-Year Est. Return

STRS Ohio Columbus, Ohio $27.1B AUM 34.64% 1-Year Est. Return

Profund Advisors Bethesda, Maryland $3.48B AUM 66.96% 1-Year Est. Return

Vise Technologies's TWST Position: Q3 2026 in Review

Vise Technologies opened a new position in Twist Bioscience (TWST) in Q3 2026: 1,924 shares worth $372K. The stake represents ﹤0.01% of the portfolio and ranks #1557 among its holdings.

94 funds tracked by Wall St. Rank hold TWST as of Q3 2026.

Vise Technologies held 1,924 shares of Twist Bioscience worth $372K as of Q3 2026.
Twist Bioscience was a new Vise Technologies position in Q3 2026.
Twist Bioscience made up ﹤0.01% of Vise Technologies's portfolio in Q3 2026, its #1557 holding.
94 funds tracked by Wall St. Rank held Twist Bioscience as of Q3 2026.

Based on Vise Technologies's 13F filing for Q3 2026, filed 29 Oct 2026.